Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02992340
Status:
TERMINATED
Last Update Posted:
2021-01-14
First Post:
2016-12-08
Brief Title:
Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC
Sponsor:
ASLAN Pharmaceuticals
Organization:
ASLAN Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-08
First Submit QC Date:
December 10 2016
Study First Post Date:
2016-12-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-12
Last Update Post Date:
2021-01-14
Last Update Post Date Type:
ACTUAL